Figure 13From: New targeted molecular therapies for cancer: radiological response in intrathoracic malignancies and cardiopulmonary toxicity: what the radiologist needs to knowDasatinib induced effusion. A. 72 year old male with CML with disease breakthrough on imatinib, 2 weeks after the switch to dasatinib. PA CXR shows bilateral effusions. B. After dose reduction 1 month later, there was interval resolution of bilateral pleural effusions.Back to article page